DISCLAIMER:
Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.
BReP-SNAP-M-59 | Development of a Machine Learning Algorithm for Hybrid Interstitial Needle Prediction in High-Dose-Rate Cervical Brachytherapy K Stenhouse*, M Roumeliotis, P McGeachy, Tom Baker Cancer Centre/University of Calgary, Calgary, AB, CA |
BReP-SNAP-T-49 | Dosimetric Performance of the Venezia™ Advanced Gynecological Applicator for Cervical Adenocarcinoma Boost Treatments: An Initial Statistical Evaluation of 125 Treatments E Schnell*, S Thompson, S Ahmad, T Herman, T De La Fuente Herman, University of Oklahoma Health Sciences Center, Oklahoma City, OK |
PO-GeP-P-84 | Multichannel Vaginal Cylinder Commissioning and Dosimetric Evaluation K Dou1*, B Li1, F Lerma1, M Jacobs2, A Halthore2 (1) MedStar Health RadAmerica, Baltimore, MD, (2) Mercy Medical Center Radiation Oncology, Baltimore, MD |
PO-GeP-T-162 | Brachytherapy Workflow for Locally Advanced Cervical Cancer: A Survey of Canadian Medical Physicists G Menon*, L Baldwin, B Burke, A Heikal, Cross Cancer Institute, Edmonton, AB, CA |
PO-GeP-T-196 | Commissioning and Dosimetric Analysis of Indigenously Developed Interstitial Plus Intracavitary Gynaecological Template in High Dose Rate Brachytherapy Venkatesan Kaliyaperumal*, S Banerjee, S Abraham, D Kamaraj, M Raju, D Manigandan, T Kataria, Medanta The Medicity, Gurgaon, Haryana, INDIA, |
PO-GeP-T-264 | Design, Production and Evaluation of Personalized 3D-Printed IC-Brachytherapy Applicators B Basaric1*, L Morgan2, C Engelberts3, M Crocker4, R Orbovic5, E Orton6, J Robar7, (1),(2),(3),(5),(6) Adaptiiv Medical Techologies, Halifax, NS,CA, (4) Dalhousie University, Halifax, NS,CA,(7) Nova Scotia Health Authority, Halifax,NS,CA |
PO-GeP-T-323 | Dosimetric Characterization of Bonvoisin-Gerard Esophageal Applicators with High Contrast Agent K Xu1*, B Traughber1,2, E Harris1,2, T Podder1,2, (1) University Hospitals Cleveland Medical Center, Cleveland, OH, (2) Case Western Reserve University, Cleveland, OH |
PO-GeP-T-333 | Dosimetric Comparison of Vaginal Ovoid with Cylinder Brachytherapy for Borderline Size of Tumor at the Vaginal Cuff X Wu*, A Nikolaev, D Bridges, S Shen, R Kim, Univ Alabama Birmingham, Birmingham, AL |
PO-GeP-T-335 | Dosimetric Effect of the Applicator Removal From Target Volumes for Cervical Cancer Patients Treated with the Venezia Applicator Z Xu1*, B Traughber1,2, E Harris1,2, T Podder1,2, (1) University Hospital Seidman Cancer Center, Cleveland, OH, (2) Case Western Reserve University, Cleveland, OH |
PO-GeP-T-516 | Incorporating Total Treatment Time Into Butterfly Optimization for Vaginal Cylinder Brachytherapy X Wu*, I Brezovich, S Shen, E Covington, D Stanley, R Popple, Univ Alabama Birmingham, Birmingham, AL |
PO-GeP-T-527 | Intracavitary Versus Combined Intracavitary/Interstitial Applicators During High Dose Rate (HDR) Image Guided Adaptive Brachytherapy (IGABT) for Cervical Cancer: A Dosimetric Comparison D Soultan*, T Bodine, A Hoover, Kansas University Medical Center, Department of Radiation Oncology, Kansas City, KS |
PO-GeP-T-762 | The Development of a Multi-Material 3D Printed Brachytherapy Training Phantom for Enhanced Resident Training S Campelo1*, E Subashi2, Z Chang3, S Meltsner3, J Chino3, O Craciunescu3, (1) Duke Medical Physics Graduate Program, Durham, NC, (2) Memorial Sloan Kettering Cancer Center, New York, NY, (3) Duke University Medical Center, Durham, NC |
TH-A-TRACK 3-6 | Custom Template Design and Manufacture Automation for Interstitial Gynecological Brachytherapy M Kudla1*,J Moore1,2,J Crook1,2,D Batchelar1,2, F Bachand1,2, (1) University of British Colombia, Kelowna, BC, CA, (2) BC Cancer - Kelowna, Kelowna, BC, CA |
TH-AB-TRACK 4-12 | Validation of a Machine Learning Algorithm for Applicator Selection in High-Dose-Rate Cervical Brachytherapy K Stenhouse*, M Roumeliotis, P McGeachy, Tom Baker Cancer Centre/University of Calgary, Calgary, AB, CA |
TU-C-TRACK 3-1 | A Novel Minimally Invasive Dynamic Shield System for Cervix Brachytherapy M Morcos1,2*, A Viswanathan2, S Abbasinejad Enger1,3,4, (1) Medical Physics Unit, McGill University, Montreal, QC, CA, (2) Johns Hopkins University, Baltimore, MD, (3) Department of Oncology, McGill University, Montreal, QC, CA, (4) Research Institute of the McGill University Health Centre, Montreal, QC, CA |